Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F George

Showing results (151-160 of 176) with videos related to

Pageof 18
Sort By:
Journal of Medicinal Chemistry|September 1, 1990
Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 3. Aromatic amine analoguesA J Lin, L Q Li, D L Klayman, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Factors affecting the absolute bioavailability of nifedipineT J Rashid, U Martin, H Clarke, et al.
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1976
Contribution of the liver to overall elimination of propranololC F George, M L Orme, P Buranapong, et al.
Gut|January 1, 1985
Pharmacology of propranolol in patients with cirrhosis and portal hypertensionM J Arthur, A R Tanner, C Patel, et al.
British Journal of Clinical Pharmacology|June 1, 1988
The pharmacokinetics of oral nifedipine--a population studyA G Renwick, D R Robertson, B Macklin, et al.
British Journal of Clinical Pharmacology|April 1, 1991
The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteersD R Robertson, I Higginson, B S Macklin, et al.
British Journal of Clinical Pharmacology|April 1, 1991
Ethnic differences in the pharmacokinetics of oral nifedipineC H Ahsan, A G Renwick, B Macklin, et al.
Clinical Pharmacokinetics|September 1, 1986
Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazoneH A Strong, R Angus, J Oates, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Factors affecting the pharmacokinetics of nifedipineA G Renwick, J Le Vie, V F Challenor, et al.
Medical Education|July 1, 1985
Education of medical students in relation to drug development, safety and efficacyC F George, D M Burley, H A Brant, et al.
Pageof 18

Showing results (151-160 of 176) with videos related to

Sort By:
Pageof 18
Journal of Medicinal Chemistry|September 1, 1990
Antimalarial activity of new water-soluble dihydroartemisinin derivatives. 3. Aromatic amine analoguesA J Lin, L Q Li, D L Klayman, et al.
British Journal of Clinical Pharmacology|July 1, 1995
Factors affecting the absolute bioavailability of nifedipineT J Rashid, U Martin, H Clarke, et al.
Journal of Pharmacokinetics and Biopharmaceutics|February 1, 1976
Contribution of the liver to overall elimination of propranololC F George, M L Orme, P Buranapong, et al.
Gut|January 1, 1985
Pharmacology of propranolol in patients with cirrhosis and portal hypertensionM J Arthur, A R Tanner, C Patel, et al.
British Journal of Clinical Pharmacology|June 1, 1988
The pharmacokinetics of oral nifedipine--a population studyA G Renwick, D R Robertson, B Macklin, et al.
British Journal of Clinical Pharmacology|April 1, 1991
The influence of protein containing meals on the pharmacokinetics of levodopa in healthy volunteersD R Robertson, I Higginson, B S Macklin, et al.
British Journal of Clinical Pharmacology|April 1, 1991
Ethnic differences in the pharmacokinetics of oral nifedipineC H Ahsan, A G Renwick, B Macklin, et al.
Clinical Pharmacokinetics|September 1, 1986
Effects of ischaemic heart disease, Crohn's disease and antimicrobial therapy on the pharmacokinetics of sulphinpyrazoneH A Strong, R Angus, J Oates, et al.
European Journal of Clinical Pharmacology|January 1, 1987
Factors affecting the pharmacokinetics of nifedipineA G Renwick, J Le Vie, V F Challenor, et al.
Medical Education|July 1, 1985
Education of medical students in relation to drug development, safety and efficacyC F George, D M Burley, H A Brant, et al.
Pageof 18